You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II adenoid cystic carcinoma of the oral cavity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Adenoid Cystic Carcinoma Trial in Boston (Radiation, Pembrolizumab)

Completed
Has Results
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Oct 8, 2022

Salivary Gland Cancer Trial in Cincinnati (Amivantamab)

Recruiting
  • Salivary Gland Cancer
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Aug 5, 2022

Adenoid Cystic Carcinoma Trial in United States (Lenvatinib)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Basking Ridge, New Jersey
  • +5 more
Jun 1, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Adenoid Cystic Carcinoma
  • Salivary Gland Cancer
  • Miami, Florida
  • +7 more
Oct 26, 2022

Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

Completed
  • Recurrent ACC, metastaticACC, Unreaectable ACC
  • Seoul, Korea, Republic of
    Department of Internal Medicine, Seoul National University Hospi
Mar 26, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Adenoid Cystic Carcinoma Trial in United States (Regorafenib)

Active, not recruiting
  • Adenoid Cystic Carcinoma
  • Basking Ridge, New Jersey
  • +4 more
Apr 26, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,

Terminated
Has Results
  • Stage I Oral Cavity Squamous Cell Carcinoma
  • Stage II Oral Cavity Squamous Cell Carcinoma
  • Buffalo, New York
  • +1 more
May 6, 2022

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Adenoid Cystic Carcinomas, Cisplatin Trial in Shanghai (Chidamide combined with cisplatin)

Completed
  • Adenoid Cystic Carcinomas
  • Cisplatin
  • Chidamide combined with cisplatin
  • Shanghai, Shanghai, China
    Kai Xue
Aug 18, 2021

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Adenoid Cystic Carcinoma Trial in Boston (Tretinoin)

Completed
Has Results
  • Adenoid Cystic Carcinoma
  • Boston, Massachusetts
  • +1 more
Jul 15, 2021

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Oct 10, 2023

Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma

Completed
Has Results
  • Recurrent Oral Cavity Adenoid Cystic Carcinoma
  • +11 more
  • Duarte, California
  • +11 more
Jul 14, 2020

Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)

Not yet recruiting
  • Oropharyngeal Dysplasia
  • +2 more
  • Miami, Florida
    University of Miami
May 9, 2023

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +19 more
  • Duarte, California
  • +18 more
Aug 24, 2022

Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in Guangzhou, Guanzhou (sintilimab, paclitaxel,

Recruiting
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • sintilimab, paclitaxel, carboplatin
  • Surgical resection
  • Guangzhou, Guangdong, China
  • +1 more
Feb 23, 2022